Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery
- PMID: 9179920
- DOI: 10.1016/s0143-4004(97)80061-6
Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery
Abstract
In view of the pathological placental features of pre-eclampsia and intrauterine growth restriction (IUGR), and the angiogenic effects of vascular endothelial growth factor (VEGF), the aim of this study was to determine the expression of VEGF in placentae from normal pregnancies and to compare the results with placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction (IUGR). ELISA was used to measure circulating VEGF immunoreactivity in umbilical vein serum samples and immunohistochemistry was used to determine tissue expression of the protein. Since VEGF is known to be upregulated by hypoxia, the expression pattern of VEGF would provide further clues to the oxygen status in the placentae at the time of sampling, presently a subject under great debate. The geometric mean concentration of VEGF immunoreactivity in umbilical vein serum of normal pregnant women was 112.46 pg/ml, in women with pre-eclampsia 50.23 pg/ml and in IUGR alone 175.35 pg/ml. These values were not statistically different from each other. Immunolocalization of VEGF in normal term villous placenta was observed in the syncytiotrophoblast with less intense staining in stromal cells. No qualitative differences in localization of staining between the groups (normal pregnancies, pre-eclampsia, pre-eclampsia plus IUGR, and IUGR) was found. Intensity of staining in stromal cells was also similar in the groups studied. However, intensity of VEGF immunostaining in syncytiotrophoblast was significantly reduced in the three pathological groups (P < 0.02) compared with the control group. These results suggest that reduced VEGF may be responsible, at least in part, for the impaired vascular development which occurs in these conditions. Our results are therefore not consistent with villous placental hypoxia at the time of sample collection.
Similar articles
-
Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.Lab Invest. 1999 Feb;79(2):151-70. Lab Invest. 1999. PMID: 10068204
-
Expression of vascular endothelial growth factor in third-trimester placentas is not increased in growth-restricted fetuses.J Soc Gynecol Investig. 2001 Mar-Apr;8(2):77-82. J Soc Gynecol Investig. 2001. PMID: 11336877
-
VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia.Br J Obstet Gynaecol. 1996 Dec;103(12):1191-6. doi: 10.1111/j.1471-0528.1996.tb09627.x. Br J Obstet Gynaecol. 1996. PMID: 8968234
-
Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.Placenta. 2000 Mar-Apr;21 Suppl A:S16-24. doi: 10.1053/plac.1999.0524. Placenta. 2000. PMID: 10831117 Review.
-
[Placental gene activity of significant angiogenetic factors in the background of intrauterine growth restriction].Orv Hetil. 2017 Apr;158(16):612-617. doi: 10.1556/650.2017.30622. Orv Hetil. 2017. PMID: 28415865 Review. Hungarian.
Cited by
-
Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.Mech Dev. 2014 Aug;133:163-76. doi: 10.1016/j.mod.2014.04.001. Epub 2014 Apr 19. Mech Dev. 2014. PMID: 24751645 Free PMC article.
-
HIF-1α regulated pathomechanism of low birth weight through angiogenesis factors in placental Plasmodium vivax infection.F1000Res. 2024 Jun 5;11:131. doi: 10.12688/f1000research.73820.3. eCollection 2022. F1000Res. 2024. PMID: 38884107 Free PMC article.
-
Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.Clin Sci (Lond). 2009 Feb;116(3):265-72. doi: 10.1042/CS20080270. Clin Sci (Lond). 2009. PMID: 18826376 Free PMC article.
-
Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy.Placenta. 2013 Dec;34(12):1170-6. doi: 10.1016/j.placenta.2013.09.016. Epub 2013 Oct 2. Placenta. 2013. PMID: 24161217 Free PMC article.
-
Molecular regulators of defective placental and cardiovascular development in fetal growth restriction.Clin Sci (Lond). 2024 Jul 3;138(13):761-775. doi: 10.1042/CS20220428. Clin Sci (Lond). 2024. PMID: 38904187 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources